MAGTIDLIRA 33
R2 600,00
UPA TIDLIRA 30MG PEN is a dual-agonist peptide with GLP-1 and GIP receptors which helps one lose fat loss, improve metabolic balance and suppresses one’s appetite.
Guarantee safe & secure checkout
Description
MAGTIDLIRA 33™ – Dual-Action Weight Loss Pen
(Semaglutide 3 mg + Tirzepatide 30 mg)
The Ultimate Synergy for Appetite Control, Fat Reduction & Metabolic Optimization
Experience the next evolution in GLP-1 therapy with MAGTIDLIRA 33™, a breakthrough dual-action injectable combining Semaglutide and Tirzepatide for unmatched weight-loss performance and metabolic balance.
Additional information
| Colour | Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow |
|---|
Quick Comparison
| MAGTIDLIRA 33 remove | Nova Cardiogen remove | BP Cagri 12 remove | NOVA Immune Booster remove | HDL Semag 10 remove | BP BPC157 & TB500 remove | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | MAGTIDLIRA 33 remove | Nova Cardiogen remove | BP Cagri 12 remove | NOVA Immune Booster remove | HDL Semag 10 remove | BP BPC157 & TB500 remove | ||||||||||||
| Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ||||||||||||
| SKU | IN_LK-38 | IN_LK-16 | IN_LK-1 | IN_LK-20 | IN_LK-11 | IN_LK | ||||||||||||
| Rating | ||||||||||||||||||
| Price | R2 600,00 | R1 300,00 | R2 600,00 | R1 500,00 | R1 450,00 | R2 200,00 | ||||||||||||
| Stock | ||||||||||||||||||
| Weight | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Additional information |
|
|
|
|
|
| ||||||||||||
| Description | UPA TIDLIRA 30MG PEN is a dual-agonist peptide with GLP-1 and GIP receptors which helps one lose fat loss, improve metabolic balance and suppresses one's appetite. | Cardiogen is a premium cardiovascular-support formula designed to improve heart health, enhance circulation, and support healthy blood pressure levels. | Treats type 2 diabetes and aids in long-term weight management. | Supports immune function, recovery, and inflammation balance with Thymosin Alpha 1 for stronger immune resilience. | Semaglutide activates the GLP-1 (glucagon-like peptide-1) receptor, producing multiple downstream effects: enhanced insulin secretion in response to meals, suppressed glucagon output, delayed gastric emptying, and reduced appetite signals. | This blend combines two well-studied regenerative peptides: BPC-157 (Body Protection Compound-157), a pentadecapeptide derived from human gastric juice with cytoprotective and wound-healing properties[1][2], and TB-500 (Thymosin Beta-4 fragment), a 43-amino-acid peptide involved in tissue repair, cell migration, and angiogenesis[3][4]. | ||||||||||||
| Add to cart |

Reviews
There are no reviews yet.